Tofacitinib 60505-6263-06
- Manufacturer
- Apotex Corp.
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- June 3, 2026
- Listing Expires
- December 31, 2027
- Application
- ANDA218096
Need to source Tofacitinib? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Tofacitinib | 5 mg/1 |
Drug Class
Janus Kinase Inhibitor [EPC]Janus Kinase Inhibitor [EPC]Janus Kinase Inhibitors [MoA]
Selected Package
60505-6263-06Selected60 TABLET, FILM COATED in 1 BOTTLE (60505-6263-6)
Other packages for this product(1)
500 TABLET, FILM COATED in 1 BOTTLE (60505-6263-5)